Monday, March 2, 2009

Interferon lambda has been cleared

"ZymoGenetics Inc. (ZGEN: News ) announced that its collaboration with Bristol-Myers Squibb Co. (BMY: News ) for hepatitis C compound PEG-Interferon lambda has been cleared by the United States Federal Trade Commission and Department of Justice clearance under provisions of the Hart-Scott-Rodino Antitrust Improvements Act."

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home